LQDA Q4 2018 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$568,402-68.7% YoY

Gross Profit

-$121M-21235.2% margin

Operating Income

-$10M-1717.0% margin

Net Income

-$10M-1704.0% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+234.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$469,574

Balance Sheet

Total Assets

$49M

Total Liabilities

$31M

Stockholders' Equity

$19M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$568,402	$2M	-68.7%
Gross Profit	-$121M	$2M	-7052.2%
Operating Income	-$10M	-$7M	-35.8%
Net Income	-$10M	$8M	-218.0%

Revenue Segments

Research And Development Services

$568,402100%